Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells.
Probiotics have been used as alternative prevention and therapy modalities in intestinal inflammatory disorders including inflammatory bowel diseases (IBD) and necrotizing enterocolitis (NEC). Pathophysiology of IBD and NEC includes the production of diverse lipid mediators, including platelet-activ...
Main Authors: | Alip Borthakur, Sumit Bhattacharyya, Anoop Kumar, Arivarasu Natarajan Anbazhagan, Joanne K Tobacman, Pradeep K Dudeja |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3794005?pdf=render |
Similar Items
-
Correction: Lactobacillus acidophilus Alleviates Platelet-Activating Factor-Induced Inflammatory Responses in Human Intestinal Epithelial Cells.
by: Alip Borthakur, et al.
Published: (2015-01-01) -
Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells
by: Ya-Nan Cao, et al.
Published: (2018-01-01) -
<i>Lactobacillus acidophilus</i>
LA14 Alleviates Liver Injury
by: Longxian Lv, et al.
Published: (2021-06-01) -
Microencapsulation of Lactobacillus acidophilus and Lactobacillus johnsonii
by: Chia-Wen Kuo, et al.
Published: (2014) -
Prevention of necrotizing enterocolitis through surface layer protein of Lactobacillus acidophilus CICC6074 reducing intestinal epithelial apoptosis
by: Yuxing Guo, et al.
Published: (2018-08-01)